Momentum, NMSS Magazine – A big part of the MS puzzle
/0 Comments/in 2019, News, Latest News /by Stephanie TuazonFibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease Model, Published in Neuron, Mar 2019
/0 Comments/in 2019, News, Latest News /by Stephanie TuazonFebruary 5, 2019
Gladstone scientists Katerina Akassoglou and Mario Merlini found that a blood protein destroys memory storage sites in the brain and may lead to new treatments.
Click Here to read full article
New Immunotherapy Targeting Blood-Clotting Protein Protects MS and AD, Published in Nat Immunol 2018
/0 Comments/in 2018, News, Latest News /by Stephanie Tuazon$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
/0 Comments/in Latest News /by Stephanie TuazonOctober 31, 2019
Click here to read full article.
Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
At the Bench: Katerina Akassoglou, PhD, on the Role of Blood Proteins in Neurologic Disease
/0 Comments/in News, 2016, Latest News /by awp-adminKaterina Akassoglou, Ph.D.
Gladstone Institute of Neurological Disease
1650 Owens Street
San Francisco, CA 94158
415-734-2512 (Phone)
415-355-0824 (Fax)
kakassoglou@gladstone.ucsf.edu